- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07946835
The Effects of Virtual Reality-Based Relaxation on Postoperative Symptoms and Patient Satisfaction Among Adolescents Undergoing Emergency Surgery
Investigation of the Effects of Virtual Reality-Based Relaxation Exercises on Postoperative Symptom Management and Patient Satisfaction in Adolescents Undergoing Emergency Surgical Intervention
The aim of this study is to evaluate the effects of virtual reality-based progressive relaxation exercises on surgery-related symptoms and patient satisfaction among adolescents undergoing emergency surgery. Specifically, the study will investigate the effects of these exercises on preoperative and postoperative anxiety levels, pain intensity scores, nausea and vomiting scores, time to mobilization (hours), total length of hospital stay (hours), and patient satisfaction.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
The aim of this study is to evaluate the effects of virtual reality-based progressive relaxation exercises on surgery-related symptoms and patient satisfaction in adolescents undergoing emergency surgical procedures. Specifically, the study will examine the effects of this intervention on preoperative and postoperative anxiety levels, pain intensity, nausea and vomiting severity, time to first mobilization (hours), total length of hospital stay (hours), and patient satisfaction.
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Aynur Çakmak, PhD Student
- Numero di telefono: +90 555 689 43 12
- Email: aynurcakmak3@gmail.com
Backup dei contatti dello studio
- Nome: Fatma Vural, Professor
- Numero di telefono: +90 532 476 37 81
- Email: fatma.vural@deu.edu.tr
Luoghi di studio
-
-
Balçova
-
Izmir, Balçova, Turchia (Türkiye)
- Dokuz Eylül University Research and Application Hospital
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Inclusion Criteria:
- Adolescents aged 12-18 years who voluntarily agree to participate in the study,
- Undergoing surgery for the first time,
- Scheduled to undergo emergency surgery within 24 hours of hospital admission (appendicitis, ovarian torsion, testicular torsion, or Meckel's diverticulum),
- Having no chronic diseases (e.g., diabetes, hypertension, asthma, cerebral palsy, epilepsy, cystic fibrosis, etc.),
- Having no visual, hearing, or physical disabilities,
- Being oriented to person, place, and time,
- Having no cognitive impairment that would affect their ability to express themselves,
- Adolescents for whom written informed consent has been obtained from both the adolescent and their parent.
Exclusion Criteria:
- Adolescents who do not complete all stages of the study,
- Adolescents who are admitted to the intensive care unit after surgery,
- Adolescents whose surgery is postponed beyond the first 24 hours,
- Adolescents who undergo surgery due to perforated appendicitis,
- Adolescents diagnosed with migraine, vertigo, or similar conditions,
- Adolescents who experience hemodynamic instability when wearing the VR headset.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Intervention Group: Virtual Reality
Adolescents and their parents will be informed about the study, and written informed consent will be obtained. Baseline data will be collected using the Adolescent Descriptive Characteristics Form, Vital Signs Monitoring Form, Visual Analog Scale (VAS), and Spielberger State Anxiety Inventory (STAI-S). Participants will receive instructions on VR headset use and relaxation exercises. Before surgery, vital signs, pain, and anxiety will be reassessed. Postoperatively, vital signs, pain, anxiety, and nausea (BARF scale) will be evaluated. At the fourth postoperative hour, following adequate recovery from anesthesia, the VR-based relaxation intervention will be administered. All clinical outcomes will be reassessed at the sixth postoperative hour. Before discharge, patient satisfaction (VAS-S), time to first mobilization, and length of hospital stay will be recorded. |
The virtual reality (VR) intervention was implemented using an Oculus Quest 2 headset, selected to ensure patient safety and ease of use. The device is rechargeable, operates independently without requiring a computer connection, weighs 503 g, and is secured to the user's head using adjustable, soft straps. Its hand-tracking feature enables participants to interact naturally with virtual environments using their own hands, without the need for handheld controllers. The VR-based relaxation program lasts 16 minutes and incorporates rhythmic breathing, controlled exhalation, and progressive muscle relaxation exercises. The progressive muscle relaxation component targets several muscle groups, including the arms and hands, neck, chest and abdomen, legs and hips, back and shoulders, eyes and head, and feet and lower legs. |
|
Nessun intervento: Control Group: Standard Care
During the preoperative period, adolescents and their parents will be informed about the surgical process, and appropriate measures will be taken to ensure patient safety. Adolescents and their parents will also be informed about the study, and written informed consent will be obtained from both parties. During the initial face-to-face interview, data will be collected using the Adolescent Descriptive Characteristics Form, Vital Signs Monitoring Form, Visual Analog Scale (VAS), and Spielberger State-Trait Anxiety Inventory - State Version (STAI-S). Demographic and clinical data will be obtained from the adolescents, their parents, and medical records. Before surgery, vital signs, pain intensity, and state anxiety levels will be reassessed. At the fourth postoperative hour, vital signs, pain intensity, state anxiety, and nausea will be assessed using the BARF scale, while routine nursing care will be provided. At the sixth postoperative hour, these clinical outcomes will be reassessed. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Preoperative Anxiety Level
Lasso di tempo: 6 months
|
Anxiety will be assessed using the Spielberger State Anxiety Inventory (STAI-S), a 20-item scale with total scores ranging from 20 to 80, with higher scores indicating higher levels of anxiety. Two assessments will be conducted during the preoperative period: the first immediately upon the patient's arrival at the surgical ward and the second 30 minutes before transfer to the operating room. |
6 months
|
|
Postoperative Anxiety Level
Lasso di tempo: 6 months
|
Postoperative anxiety will be assessed on postoperative day 0 using the Spielberger State Anxiety Inventory (STAI-S), a 20-item self-report instrument scored on a 4-point Likert scale, with total scores ranging from 20 to 80. Higher scores indicate greater levels of postoperative anxiety. Assessments will be conducted at two time points: 4 and 6 hours after surgery (postoperative day 0). |
6 months
|
|
Postoperative Pain Intensity
Lasso di tempo: 6 months
|
Postoperative pain intensity will be assessed on postoperative day 0 (POD 0) using a 10-cm Visual Analog Scale (VAS), with scores ranging from 0 to 10. A score of 0 indicates no pain, whereas a score of 10 represents the worst imaginable pain. Assessments will be performed at 4 and 6 hours after surgery. |
6 months
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Postoperative Nausea Severity
Lasso di tempo: 6 months
|
Postoperative nausea severity will be assessed using the Baxter Retching Faces (BARF) Scale, with scores ranging from 0 to 10. A score of 0 indicates no nausea, whereas a score of 10 represents the most severe nausea. Assessments will be conducted at two time points: 4 and 6 hours after surgery. |
6 months
|
|
Postoperative Length of Hospital Stay
Lasso di tempo: 6 months
|
Total duration of postoperative hospitalization, measured in hours from the completion of the surgical procedure until the adolescent patient is formally discharged from the hospital. |
6 months
|
|
Patient satisfaction level
Lasso di tempo: 6 months
|
Visual Analog Scale for Satisfaction (VAS-S): Patient satisfaction with nursing care will be assessed using a 10-cm visual analog scale ranging from 0 (not satisfied at all) to 10 (completely satisfied), with higher scores indicating greater satisfaction. The assessment will be performed at the 6th postoperative hour on the day of surgery (POD 0). |
6 months
|
|
At the First Postoperative Mobilization Session
Lasso di tempo: 6 months
|
The total duration (in minutes) of active ambulation performed by the adolescent patient during the first postoperative mobilization session on postoperative day 0 (POD 0). |
6 months
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
- DEU-SBF-AC-01
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .